Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art - PubMed (original) (raw)

Review

Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art

Francesco Bonatti et al. Front Immunol. 2014.

Abstract

ANCA-associated vasculitis (AAV) is a group of disorders that is caused by inflammation affecting small blood vessels. Both arteries and veins are affected. AAV includes microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA) renamed from Wegener's granulomatosis, and eosinophilic granulomatosis with polyangiitis (EGPA), renamed from Churg-Strauss syndrome. AAV is primarily due to leukocyte migration and resultant damage. Despite decades of research, the mechanisms behind AAV disease etiology are still not fully understood, although it is clear that genetic and environmental factors are involved. To improve the understanding of the disease, the genetic component has been extensively studied by candidate association studies and two genome-wide association studies. The majority of the identified genetic AAV risk factors are common variants. These have uncovered information that still needs further investigation to clarify its importance. In this review, we summarize and discuss the results of the genetic studies in AAV. We also present the novel approaches to identifying the causal variants in complex susceptibility loci and disease mechanisms. Finally, we discuss the limitations of current methods and the challenges that we still have to face in order to incorporate genomic and epigenomic data into clinical practice.

Keywords: ANCA-associated vasculitis; eosinophilic granulomatosis with poliangiitis; genome-wide association studies; granulomatosis with poliangiitis; microscopic poliangiitis; pharmacogenetics; rituximab.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol (2013) 8:139–60.10.1146/annurev-pathol-011811-132453 - DOI - PMC - PubMed
    1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 37:187–92.10.1002/art.1780370206 - DOI - PubMed
    1. Falk RJ, Jennette JC. ANCA disease: where is this field heading? J Am Soc Nephrol (2010) 21:745–52.10.1681/ASN.2009121238 - DOI - PubMed
    1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum (2013) 65:1–1110.1002/art.37715 - DOI - PubMed
    1. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR project for anca assay standardization. Kidney Int (1998) 53:743–53.10.1046/j.1523-1755.1998.00807.x - DOI - PubMed

Publication types

LinkOut - more resources